(Q44892761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jan Walewski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marek Wojtukiewicz

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

18

Holowiecki J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

20

Jedrzejczak WW

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

8

Robak T

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Czyz J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Knopinska-Posluszny W

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hellmann A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gozdzik J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hansz J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Smolewski P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Osowiecki M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Avigdor A

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nagler A

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Zemelka T

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Pawlicki M

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sawicki Z

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kachel L

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Charlinski G

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1225-1229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094747%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704508

27 December 2019

exact match

0 references

cites work

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

7 January 2021

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

7 January 2021

High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

7 January 2021

Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704508

7 January 2021